• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短期“逃逸”和长期“漂移”。β肾上腺素能阻滞剂的消散效应。

Shortterm "escape" and longterm "drift." The dissipation effects of the beta adrenergic blocking agents.

作者信息

Boger W P

出版信息

Surv Ophthalmol. 1983 Dec;28 Suppl:235-42. doi: 10.1016/0039-6257(83)90138-8.

DOI:10.1016/0039-6257(83)90138-8
PMID:6141645
Abstract

The dissipation phenomena associated with timolol have important implications in the clinical management of glaucoma patients. Shortterm "escape" and longterm "drift" are clinical terms which describe the reduction of timolol's efficacy over a few days and over months and years, respectively. Recent physiological studies suggest a cellular explanation for these readjustments in tissue responsiveness to continued administration of timolol. While the precise location of the physiologically responding cells and the interactions of the various adrenergic responsive elements remain unclear, subsensitivity and supersensitivity may prove to be the most accurate designations for alterations in tissue responsiveness to adrenergic stimulation following "down regulation" or "up regulation" of beta receptor density on cell membranes.

摘要

与噻吗洛尔相关的药效消散现象在青光眼患者的临床治疗中具有重要意义。短期“逃逸”和长期“漂移”是临床术语,分别描述了噻吗洛尔在几天内以及数月和数年内疗效的降低。最近的生理学研究为组织对持续使用噻吗洛尔的反应性重新调整提供了一种细胞层面的解释。虽然生理反应细胞的确切位置以及各种肾上腺素能反应元件之间的相互作用尚不清楚,但在细胞膜上β受体密度发生“下调”或“上调”后,组织对肾上腺素能刺激的反应性改变,用亚敏感性和超敏感性来描述可能最为准确。

相似文献

1
Shortterm "escape" and longterm "drift." The dissipation effects of the beta adrenergic blocking agents.短期“逃逸”和长期“漂移”。β肾上腺素能阻滞剂的消散效应。
Surv Ophthalmol. 1983 Dec;28 Suppl:235-42. doi: 10.1016/0039-6257(83)90138-8.
2
Serial administration of adrenergic antagonist and agonist ("pulsatile therapy") reduces the incidence of long-term drift to timolol in humans.
Invest Ophthalmol Vis Sci. 1996 Mar;37(4):684-8.
3
Timolol in the therapy of "ocular hypertension".噻吗洛尔在“高眼压症”治疗中的应用
Surv Ophthalmol. 1980 Nov-Dec;25(3):195-202. doi: 10.1016/0039-6257(80)90098-3.
4
Role of the beta-adrenergic receptor-binding agent 'timolol' in the treatment of open-angle glaucoma.
Ophthalmologica. 1982;184(4):198-203. doi: 10.1159/000309206.
5
A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF2 alpha metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension.0.5%马来酸噻吗洛尔与PGF2α代谢物的二十二碳类衍生物0.12%乌诺前列酮对慢性开角型青光眼或高眼压症患者降眼压效果的比较。
Curr Med Res Opin. 1999;15(2):87-93. doi: 10.1185/03007999909113368.
6
Comparison of 24-hour intraocular pressure reduction with two dosing regimens of latanoprost and timolol maleate in patients with primary open-angle glaucoma.原发性开角型青光眼患者中拉坦前列素两种给药方案与马来酸噻吗洛尔24小时眼压降低情况的比较。
Am J Ophthalmol. 1999 Jul;128(1):15-20. doi: 10.1016/s0002-9394(99)00073-2.
7
The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.双氯芬酸眼药水对原发性开角型青光眼患者局部使用0.5%噻吗洛尔和0.005%拉坦前列素降眼压效果的影响。
Exp Eye Res. 2005 Nov;81(5):610-5. doi: 10.1016/j.exer.2005.03.020. Epub 2005 Jun 8.
8
Circadian intraocular pressure and blood pressure reduction with timolol 0.5% solution and timogel 0.1% in patients with primary open-angle glaucoma.原发性开角型青光眼患者应用噻吗洛尔 0.5% 滴眼剂和凝胶 0.1% 对眼压和血压的昼夜节律影响
J Clin Pharmacol. 2012 Oct;52(10):1552-7. doi: 10.1177/0091270011420254. Epub 2011 Nov 22.
9
Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.在原发性开角型青光眼或高眼压患者中,比较每日两次给予1%布林佐胺滴眼液和2%多佐胺滴眼液并联合0.5%噻吗洛尔滴眼液的疗效。
Am J Ophthalmol. 2001 Aug;132(2):235-43. doi: 10.1016/s0002-9394(01)00974-6.
10
Comparative efficacy of orally and topically administered beta blockers for chronic simple glaucoma.口服和局部应用β受体阻滞剂治疗慢性单纯性青光眼的疗效比较
Br J Ophthalmol. 1985 Jan;69(1):41-5. doi: 10.1136/bjo.69.1.41.

引用本文的文献

1
Standalone interventional glaucoma: evolution from the combination-cataract paradigm.独立介入性青光眼:从白内障联合模式的演变。
J Cataract Refract Surg. 2024 Dec 1;50(12):1284-1290. doi: 10.1097/j.jcrs.0000000000001537.
2
Evaluation of the Efficacy Duration of Topical Therapies in Eyes with Primary Open-Angle Glaucoma.原发性开角型青光眼眼部局部治疗疗效持续时间的评估
J Clin Med. 2022 Oct 19;11(20):6166. doi: 10.3390/jcm11206166.
3
Topical timolol 0.5% gel-forming solution for erythema in rosacea: A quantitative, split-face, randomized, and rater-masked pilot clinical trial.
0.5%噻吗洛尔凝胶形成溶液治疗酒渣鼻红斑:一项定量、半脸、随机、评估者盲法的试点临床试验。
J Am Acad Dermatol. 2021 Oct;85(4):1044-1046. doi: 10.1016/j.jaad.2021.01.098. Epub 2021 Feb 3.
4
Effect of preservative removal from fixed-combination bimatoprost/timolol on intraocular pressure lowering: a potential timolol dose-response phenomenon.从固定复方比马前列素/噻吗洛尔中去除防腐剂对降低眼压的影响:一种潜在的噻吗洛尔剂量反应现象。
Clin Ophthalmol. 2016 Mar 3;10:373-83. doi: 10.2147/OPTH.S98898. eCollection 2016.
5
Clinical effectiveness of brinzolamide 1%-brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension.1%布林佐胺-0.2%溴莫尼定固定复方制剂用于原发性开角型青光眼和高眼压症的临床疗效
Clin Ophthalmol. 2015 Nov 24;9:2201-7. doi: 10.2147/OPTH.S72380. eCollection 2015.
6
Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination.从非固定复方制剂换用0.005%拉坦前列素+0.5%马来酸噻吗洛尔固定复方制剂12个月后眼压降低效果及安全性评估
Clin Ophthalmol. 2012;6:607-12. doi: 10.2147/OPTH.S30611. Epub 2012 Apr 18.
7
Pharmacological management of primary open-angle glaucoma: second-line options and beyond.原发性开角型青光眼的药物治疗:二线及其他治疗选择
Drugs Aging. 2008;25(9):729-59. doi: 10.2165/00002512-200825090-00002.
8
Latanoprost : an update of its use in glaucoma and ocular hypertension.拉坦前列素:其在青光眼和高眼压症治疗中的应用进展
Drugs Aging. 2003;20(8):597-630. doi: 10.2165/00002512-200320080-00005.
9
New developments in the drug treatment of glaucoma.青光眼药物治疗的新进展。
Drugs. 1991 Apr;41(4):514-32. doi: 10.2165/00003495-199141040-00002.
10
Long-term drift and timolol therapy: possible role for pulsed therapy.
Int Ophthalmol. 1992 Sep;16(4-5):321-4. doi: 10.1007/BF00917984.